Adherence to medication in bipolar disorder: a qualitative study exploring the role of patients' beliefs about the condition and its treatment. by Clatworthy, J et al.
1Adherence to medication in bipolar disorder: a qualitative study exploring
the role of patients’ beliefs about the condition and its treatment
Jane Clatworthy1, Richard Bowskill2, Tim Rank3, Rhian Parham1 and Robert Horne1
1 Centre for Behavioural Medicine, The School of Pharmacy, University of London
2 Postgraduate Medical School, University of Brighton
3 South Downs Health NHS Trust
Corresponding author:
Professor Rob Horne
Director
Centre for Behavioural Medicine
Department of Policy & Practice
The School of Pharmacy
University of London
Mezzanine Floor, BMA House
Tavistock Square
London WC1H 9JP
Phone: +44 (0) 20 7874 1270
Fax: 00 44 (0) 207 387 5693
Email: rob.horne@pharmacy.ac.uk
Running head: Medication adherence in bipolar disorder
Word Count: 6003
Funding source: This research was supported by an unrestricted educational grant from
AstraZeneca.
There are no conflicts of interest in connection with this manuscript.
2Abstract
Objectives: Patients’ perceptions of illness and treatment have been found to predict
adherence to medication in many chronic conditions. This has not yet been fully
explored in bipolar disorder. The aim was to use a qualitative methodology to explore in
depth the beliefs about bipolar disorder and its treatment that are associated with
adherence to medication prescribed for bipolar disorder
Methods: Sixteen adults prescribed prophylactic treatment for bipolar disorder
completed semi-structured interviews about their perceptions of bipolar disorder and its
treatment and their adherence to medication. Interviews were recorded and transcribed
verbatim. Two researchers identified perceptions associated with nonadherence in the
transcripts.
Results: Thirteen participants (81%) reported some degree of intentional or
unintentional medication nonadherence. Intentional nonadherence was associated with
patients’ concerns about the prescribed medication, arising from the experience of side
effects, but also from beliefs that regular use could lead to adverse effects in the future.
Intentional nonadherence was also associated with doubts about the personal need for
medication, which were related to perceptions of bipolar disorder (e.g. not accepting
diagnosis, believing the condition is not controllable, believing it is not a chronic
condition).
Conclusions: This study has identified some of the salient beliefs about bipolar
disorder and its treatment that should be elicited and addressed in interventions to
facilitate adherence to medication. Further quantitative work is justified to explore the
utility of this approach in the development of interventions.
Keywords: Patient compliance; Illness perceptions, Treatment perceptions
3Introduction
Around 40% of patients diagnosed with bipolar disorder do not adhere to prescribed
medication (1). As nonadherence is associated with higher rates of relapse (2) hospital
admission (3) and suicide (4), there is clearly a need for a better understanding of the
reasons behind nonadherence in bipolar disorder and for effective interventions to
facilitate adherence.
Whilst much of the existing research exploring nonadherence in bipolar disorder has
focussed on demographic and clinical predictors of nonadherence, a recent review of
adherence in bipolar disorder highlighted the need for more research that considers
active processes in adherence to medication (5). For example, how people make
decisions about whether or not to take medication and how people evaluate and manage
the consequences of taking medication.
One theoretical approach to addressing nonadherence that emphasises the active role
of the patient is the perceptions-practicalities framework (6). This approach
conceptualises nonadherence as a variable behaviour with both intentional and
unintentional causes. Unintentional nonadherence occurs when the patient’s intentions
to take the treatment are thwarted by lack of resources or capacity (e.g. forgetting or
misunderstanding instructions). Intentional nonadherence is the result of a deliberate
decision on the part of the patient and is best understood in terms of the beliefs and
expectations influencing patients’ motivation to begin and persist with treatment.
It follows that interventions to facilitate adherence are likely to be more effective if they
are individualised to the needs of the patient and address both the perceptual and
4practical barriers to adherence. Effective interventions to facilitate adherence to
medication in chronic illness are currently elusive (7). This may be because few
interventions have been developed around a suitable theoretical framework, as
recommended in MRC guidelines (8). The perceptions-practicalities approach utilises
Leventhal’s self-regulatory model (9) and the necessity-concerns framework (10) to
conceptualise the key beliefs influencing adherence.
Self Regulatory Model (SRM)
The SRM explains the cognitive processes underpinning people’s response to health
threats. Health threats may be internal (e.g. the experience of symptoms) or external
(e.g. a medical diagnosis). People respond by building a mental map or illness
representation to enable them to make sense of the threat and determine what to do
about it. Illness representations have five components: identity, timeline, cause,
consequences and control/cure. These can be thought of as the answers to five basic
questions about the illness or health threat: What is it? How long will it last? What
caused it? What effect will it have? Can it be controlled or cured? The answers people
find to these questions form their mental map. Illness representations also have an
emotional as well as a cognitive component. Research across a range of chronic
illnesses, including bipolar disorder (11), has shown that illness-related behaviour is
related to illness representations (12).
Necessity-Concerns Framework
The utility of self-regulatory theory in explaining variations in adherence to treatment is
enhanced by considering beliefs about treatment as well as illness (10). In the
5Necessity–Concerns framework the salient treatment beliefs are conceptualised as the
patient’s perceptions of the necessity of their treatment to maintain current and future
health, compared with their concerns about the actual and potential adverse effects of
their treatment. The utility of this framework in explaining adherence to treatment has
been shown in a variety of chronic illness groups (13), including depression (14).
Research has shown that patients’ beliefs about the need for medication are influenced
by their illness representations (15) and concerns are often related to negative attitudes
to pharmaceuticals as a whole and to beliefs about the long terms effects of medication
or that regular use will lead to dependence or addiction (13). However, although
research has identified that some concerns are common across treatments and illness
groups, others are specific to the condition and treatment. For this reason an important
first step in operationalising the framework for a particular condition is to carry out
studies to elicit the particular beliefs within that patient/treatment group.
There is currently minimal research exploring patients’ perceptions of bipolar disorder.
Pollack and Aponte (16) conducted a qualitative study, whereby fifteen inpatients with
bipolar disorder were interviewed about their perceptions of their condition. Patients
reported models of bipolar disorder that were very different from the medical model of
the condition. For example, one participant believed that their condition was a special
gift from God, whilst another believed it was caused by masturbation. Results from this
small sample of hospitalised patients (most of whom were hospitalised involuntarily),
however, would not be generalisable to the majority of bipolar patients living in the
community prescribed prophylactic treatment for bipolar disorder. Furthermore, the
study did not explore in detail patients’ perceptions of medication or adherence.
6Although the Necessity-Concerns framework has not yet been tested in bipolar disorder,
existing research appears to support the value of such an approach. For example, Keck
et al. (17) reported that patients’ perceived need for medication was a key predictor of
adherence to medication. Concerns about medication have also been associated with
nonadherence; for example, concerns about side effects (18; 19).
The aim of this study was to use the perceptions-practicalities approach as a framework
to explore in depth the beliefs that people hold about bipolar disorder and its treatment
and how such beliefs might be associated with adherence to prophylactic maintenance
treatment for bipolar disorder. This information could be used to assess whether
validated measures of illness perceptions (Illness Perceptions Questionnaire-
Revised)(20) and treatment perceptions (Beliefs about Medicines Questionnaire) (21)
address the key beliefs held by people with bipolar disorder that might be relevant to
adherence decisions.
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Participants
Sixteen people with a diagnosis of bipolar disorder were recruited through consultant
psychiatrists in a local NHS Trust. All participants were prescribed prophylactic
treatment for bipolar disorder and were treated in outpatient clinics. The medications
prescribed for bipolar disorder in the sample are displayed in Table 1. Twelve of the
participants were female and four were male. The mean age was 54 years (range 38 to
69) The Young Mania Rating Scale (YMRS) (22) and the Hamilton Rating Scale for
Depression (HRSD) (23) were conducted immediately prior to the interview. The aim
was to explore adherence to prophylactic treatment for bipolar disorder and therefore
people experiencing a severe manic or depressive episode would have been excluded
from the study. All participants recruited met the study inclusion criteria of less than 19
on YMRS and less than 18 on the HRSD. A process of sampling to thematic saturation
was used, whereby new participants were recruited and interviewed until no new themes
were identified.
Insert Table 1 about here
Procedure
Participants were given the choice of being interviewed at their home (n=12), at their
local outpatient unit (n= 2) or at the university (n=2). The interviews were conducted by
two researchers; a Specialist Registrar in Adult General Psychiatry (who was not
involved in the patients’ care) and a health psychology researcher.
8A semi-structured interview was conducted, using questions broadly based on the
perceptions-practicalities framework (6). Initial questions were general (e.g. What do you
think about your medication for bipolar disorder?) and were followed with prompts based
on the theory (e.g. How necessary do you feel the medication is for you?, Do you have
any concerns about the medication?). In addition to asking about illness and treatment
perceptions, participants were asked about their nonadherence to medication, including
stopping the medication, changing the dose of medication and forgetting to take
medication. Care was taken to question in a non-judgemental manner.
Interviews were recorded on a digital audio recorder and were transcribed verbatim.
Analysis
The coding scheme was structured around the Self-Regulation Model and the Necessity-
Concerns framework, as there is substantial support for these theoretical models in other
illness groups. Transcripts were read by two independent researchers who identified
statements in which participants’ beliefs about bipolar disorder (i.e. Identity, Cause,
Timeline, Consequences, Cure/Control) and beliefs about treatment (Necessity,
Concerns) were related to adherence behaviour. Statements were coded according to
the type of illness or treatment perception, using NVivo 2.0 software. As Necessity and
Concerns are broad concepts, these were subdivided into more specific types of
concerns and beliefs about the necessity of treatment.
Examples of unintentional nonadherence (i.e. nonadherence that was accidental and not
directly related to participants’ beliefs) were also identified.
9Through a process of consensus and conciliation the researchers reached agreement on
the coding of all of the statements regarding adherence to medication. The researchers
selected example quotes from each theme to report here.
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Results
Overview of adherence to medication
Of the sixteen participants interviewed, three did not report any nonadherence to
medication, eight reported nonadherence in the past and five reported current
nonadherence. Nonadherence took various forms. Whilst not taking prescribed
medication and taking less than instructed were the most common forms of
nonadherence, some participants reported taking more than instructed at times. For
example,
P: I can remember the last time that happened, my god, and I hadn’t been taking it
[lithium] and I was taking a hell of a lot - you know, mouthfuls - to try and stabilise
myself, but of course it’s too far gone.
I: Right, so you stopped taking it for a while and then you tried to balance it out. Ok, so
how much would you take then to compensate?
P: When you’re high you don’t really count to tell you the truth. Quite a lot.
(P1)
In addition, some participants reported experimenting with their medications.
I have been really bad sometimes when they prescribe me drugs - they give me large
quantities of potentially fatal tablets that you can easily take an overdose accidentally or
fiddle about. Because you feel so bad all the time, either up or down, you try and find
combinations of drugs that make you feel better, and sometimes you might hit on
something that will work for a little while and then it won’t work any more…The only thing
that I came up with is that if I take 200 mg of amisulpride and about 37 mg of dothiepine
within 2 hours it would actually take away the paranoia and the manic activity - the hyper
mania - completely. It takes 2 hours to work and then lasts about 24 hours, but it won’t
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work again for about 5 days. You can take 10 times that much and it won’t do anything
whatsoever, but once it has cleared your system completely and you take it again it
works again and I don’t have a clue why that is.
(P3)
Illness Perceptions
Identity
The Identity component of the self regulation model is considered to be a combination of
the signs and symptoms associated with the illness and the label given to the illness.
Whilst all participants reported having experienced symptoms associated with bipolar
disorder (e.g. periods of being manic and periods of being depressed), some questioned
their diagnosis or spoke of a period of denial over the diagnosis. Failure to accept a
diagnosis of bipolar disorder appeared to be associated with nonadherence.
I think that part of the problem may have been initially when I was diagnosed I was
rebelling against the fact that I had the label and not taking the medication as regularly
as I should have been - that is probably why I might have relapsed.
(P16)
Cause
There was no obvious relationship between participants’ belief about the cause of their
bipolar disorder and their adherence to medication. Five participants believed that
stress had caused their bipolar disorder, three thought that it was hereditary, two felt that
it was due to physical/ chemical factors, four thought that it was a mixture of these
factors and two did not know.
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Consequences
All of the participants reported negative consequences of the condition on their lives.
It is a bummer. It is horrible. It has wrecked my life since I have been about 26.
(P4)
I think that it is one of the worst things that you could possibly have.
(P6)
However, several participants also reported positive consequences of bipolar disorder.
Hyper mania - you just talk and have ideas and come up with these wonderful ideas.
The world is your oyster and you can’t do anything wrong.
(P3)
Timeline
Patients’ perceptions of the timeline of their condition appeared to affect their decision
about whether or not to adhere to treatment. Several participants reported that it took a
while to accept that bipolar disorder was a chronic condition and that medication needed
to be continued long-term.
It took me a long time to realise that it wasn’t going to [stop on its own]. Once I was
feeling better and better, about six months down the line I would think to myself ‘I am
better, I am okay’ and I would stop it or forget about it, and I would start to feel ill again
and not realise it. It takes a while to accept it. …Personally I realise that probably for the
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rest of my life I will be taking medication. Probably. You accept it, you can’t do anything
else. It took years.
(P14)
There was also evidence that a perception of bipolar disorder as a cyclical condition
could affect medication taking, with perceived need for medication differing according to
the stage of the cycle.
The last few months, or 6 months, I have only been taking one every day - sometimes
another half - because of circumstances or whatever, the time gap between the last
episodes. Because if I have an episode, I know what I am going to do is that I am not
going to go high again. I am going to go low and stay low for 9 months…I can’t see the
point of taking something as a prevention for manic, when I know that I am not going to
go manic.
(P6)
Amenability to cure or control
There was an association between believing in medication as a means of controlling
bipolar disorder and taking medication. For example, one of the three people who
reported being consistently adherent to medication expressed her confidence in the
ability of medication to control the condition:
I: Is there anything that you think you can do to control the bipolar disorder?
P: Only by taking the injections, but I am a firm believer in them.
(P7)
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In contrast, participants who had little faith in the role of medication in controlling bipolar
disorder, or who thought that there were alternative ways of controlling the condition,
appeared to be less likely to take it:
I: What about medication? Do you think that medication has a role in controlling bipolar
disorder?
P: That is difficult, I tend to think that time would heal anyway. But it’s a heck of gamble
to just leave people exhibiting the sorts of symptoms that I was exhibiting and say ‘in
time they will be all right’. I think with me though, definitely, it was a question of time will
tell - some of the medication I did not take, I was secreting it about my person or flushing
it down the loo or whatever, I was not taking it.
(P9)
Beliefs about medicines
Necessity
There were several dimensions to patients’ perceptions of the necessity of medication.
Some participants reported that they believed in the efficacy of the medication. For
example, this woman who reported high adherence:
I: How important do you feel that medication is?
P: Very important. I probably would not be here sitting and talking to you. I would be
probably, like in the olden days locked away in a mad house or not even here. So yeah.
I: How do you judge whether or not it is effective?
P: By leading a normal life.
(P14)
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Where people did not believe the medication was working, they appeared less inclined
to take it. For example, this man who experimented with his medication reported:
P: I have had have every anti psychotic going virtually, every drug that they have
available going and none of them work… and now I am at a point of where else can we
go as we haven’t got anything left.
I: Do you think that the combination of drugs that you are on at the moment is effective?
P: No. No. Sometimes they can make me feel better and sort of skim the surface, but if
you have bad hallucinations, if you have large quantities of anti-psychotics they reduce
them, but they don’t get rid of them completely.
(P3)
Another dimension of treatment necessity was simply that it was necessary because the
doctor said so. For some, this was because they appeared to trust the advice of their
doctors.
I: Do you think that the medications are controlling your bipolar disorder?
P: I don’t know now. I think that I would rather come off them and see what is happening
by myself but I was advised not to do that. I do wonder why I don’t come off them, but I
see this Dr X and he is very charming and he says “No, there is a possibility that within
the six months you could relapse, but after six months there is much less chance of
relapsing and I do suggest you hang on until then”. I say “all right then.”
(P12)
For others, however, adherence appeared to be driven by a fear of punishment if they
were not seen to by complying with the medical profession. For example,
P: Basically I don’t want to be on any medication at all, but obviously I am so concerned
that any failure to comply with the medical profession will put me back in a situation as
before… My failure to take diazepam, I believe, before to calm me down, resulted in me
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being taken to hospital - because I would not comply. If I had taken that and they had
seen me calm, I believe that they would have gone away.
I: Do you think that you would get sectioned purely for not taking it? Or would there need
to be some behaviour that would justify the sectioning?
P: In a way yeah. I see what you are saying. But in some ways I don’t want to cause
ructions, I want to be seen to be doing as I am told really.
I: Okay. Is there even a little bit of you that thinks that it might be helping in some way?
P:No.
(P5)
Concerns
There were also several dimensions to participants’ concerns about medication. One
concern that was frequently raised by participants in relation to nonadherence was that
of side effects. Several participants reported lowering the dose of medication or not
taking medication due to physical side effects.
But I have been against lithium because I had all sorts of strange side effects. One
particularly was an earache … and there were other side effects as well which I had, so I
said to them well you know I’m going to reduce it and about 3 years ago I went down to
200 [mg]. But I have prescribed for me 600 and I’ve been taking 200 now for going on
nearly a year - no over a year now - and I’m not having any side effects that I had, so for
me that’s just right. And I think that could be encouraged - not to have a set amount per
person if they say they’re having side effects, just a little bit.
(P1)
More commonly reported than concerns about physical side effects, however, was a
concern about how the medications made participants feel. In particular, participants
reported ‘not feeling themselves’ or being limited in terms of productivity and creativity.
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P: Lithium and valproate are the only stablisers that I have had - and the problem is that
they all put you into zombie mode. I think that they make you feel slightly down. All you
do is sit here and watch the tele - you won’t do anything and you don’t want to do
anything. You have got no drive, lithium and valproate, you have no drive to do anything
whatsoever.
I: Is that different from feeling depressed?
P: Yeah, it is sort of, it is feeling slightly miserable; not actually depressed, slightly
miserable or maybe not too bad, but it totally takes away your will to do anything. I had
no interest, apart from my boys, and even then I did not give them enough time. It takes
away your life, it puts you on standby and you just function. It does not make your life
better, to be quite honest. It is better than being really manic, the best is to be slightly
hyper. You might have problems sleeping but generally you feel better. It gives you a
drive to actually do something.
I: You are prescribed valporate at the moment?
P: Yes, but I don’t take it as I just go into zombie mode. I call them standby drugs. I think
that they have their place. If you are suffering from mania you have to stop it. I mean,
you could hurt someone, or yourself, and you know, you would not realise that you have
done it.
I: You would consider taking it again?
P: I have got it, and if I need it I would take it.
(BP3)
I used to see myself before bipolar being diagnosed as being more creative, more
spontaneous and now I don’t and I have put it down to the fact that I take lithium but I
don’t know how much of that is true. The longer it goes on with me taking lithium and if I
take it for the rest of my life, the further away that I get from the person that I remember
myself to be. I don’t suppose that I will ever know.
(P16)
Several participants reported taking less medication than prescribed due to concerns
about the toxicity of the drugs.
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P: I am taking it regularly, just the one.
I: One tablet a day - is that what you are prescribed to take?
P: No. I think that he would like at least 1.5 perhaps 2.
I: Why do you choose not to take 2?
P: I think that it is too much - it is like saying take four panadol or aspirin. It is hard on
the liver. Look in the news and you see the whole hype about the side effects there.
Someone told me if you took too many you would be brain dead and I think that too
many is 3 – 4 or something like that…It would actually kill you, can’t it? There was that
play on the tele a while back with a doctor who increased his wife’s lithium and managed
to kill her off like that.
(P6)
Another concern that appeared to be associated with taking less medication than
prescribed was concern about addiction to medication, particularly with reference to
benzodiazepines.
I am on Olanzapine 7.5mgs, Sodium Valproate 1200mgs, I take 15mg of Nitrazepam
and I am on Ativan which I should theoretically take four times a day but I know how
addictive it is so I only take it twice a day - in the morning and at night.
(P13)
Fear of addiction also appeared to be associated with a concern about withdrawal
effects if medication was stopped.
What worries me is the side effects of coming off. It is more the withdrawal of it than the
taking of it that worries me.
(P5)
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Unintentional Nonadherence
The most common type of unintentional nonadherence took the form of forgetting to take
medication. Participants reported that this was particularly common when they were
becoming manic. For example:
P: Once you have got to a certain stage, you don’t realise that you have got to that
stage. You can tell the signs but you think oh it does not matter, take some medication
and it will be all right. Then you get to the stage where you forget your medication and
you don’t take it. That is because you have forgotten to take it as you are having such a
good time.
I: Do you think you’re most likely to forget your medication when you start to go high?
P: As you are more active, you tend not to know the concept of time. You may be going
out and doing stuff. You think it does not matter, I will take it the following morning. It
says on the leaflet that you can take it the following morning, the problem is that once
you have done that 4 or 5 weeks, 2 – 3 weeks the medication is not working any more.
(P14)
One participant also reported being confused about how she was supposed to take her
medications at times, which could lead to unintentional nonadherence.
Yeah one time when I came out of the hospital it wouldn’t have been hard to get terribly
confused with the medication. It is confusing, especially if it has changed and you are
not really very good. You can easily make a complete mess up of it.
(P10)
Several participants reported strategies that they had in place to help prevent
unintentional nonadherence. These included attaching medication-taking to other
routine behaviours (e.g. taking medication after cleaning teeth), using dossett boxes/
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having the pharmacist package the drugs in daily bubble-packs or having relatives,
friends or support workers looking out for early signs of mania.
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Discussion
The findings support a perceptions-practicalities approach to addressing nonadherence
in bipolar disorder. There was evidence of patients making decisions about how to take
their prescribed medication on the basis of their perceptions of bipolar disorder and its
treatment. It is therefore important for health professionals to elicit and address patients’
perceptions of their condition and treatment if they are to improve adherence to
medication. A recent study of a collaborative practice model in bipolar disorder
emphasised the importance of clinicians taking an active role in understanding patients’
perceptions of bipolar disorder and its treatment, in order to form a patient-provider
relationship that facilitates adherence (24).
This study also provided evidence of unintentional nonadherence due to practical
barriers to adherence. Many participants provided examples of useful strategies for
overcoming such barriers (e.g. dossett boxes, bubble-packed drugs).
The qualitative methodology applied allowed detailed information about the types of
nonadherence to be elicited. Self-report assessment of nonadherence is often criticised
for underestimating adherence levels (25). When questioned in a non-judgemental
manner, however, participants appeared to be very open about discussing how they
used their medication. Indeed, many of the types of nonadherence disclosed would not
have been detectable by other methods. For example, if the ‘gold standard’ electronic
monitors had been used, participants who were taking medication regularly but were
only taking half the prescribed dose on each occasion would have appeared to have
perfect adherence, as they would have opened their medication containers at the right
intervals.
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It is well recognised that some of the barriers to adherence are external to the patient,
(e.g. fiscal constraints/ difficulties in ordering and collecting prescriptions)(26). These
issues may have been underrepresented within our sample, due to the focus of the
interval schedule on patients’ perceptions of bipolar disorder and its treatment within the
context of medication taking behaviour. However, all interviews began with open
questions allowing patients to focus on the issues that mattered most to them. We
cannot, of course, conclude that external factors were unimportant and further work is
needed to assess the contribution of external barriers to nonadherence in bipolar
disorder.
The qualitative methodology enabled a thorough exploration of patients’ perceptions of
bipolar disorder and its treatment, without being restricted by questionnaire-based
measures. Most of the perceptions elicited are already addressed in questionnaire-
based measures of illness and treatment perceptions (20; 21). Two themes, however,
are not currently addressed. The first is concerned with acceptance of the diagnosis.
Several participants reported that in the past they had not accepted the diagnosis of
bipolar disorder and had not therefore been prepared to take medication for a condition
that they did not believe that they had. Previous research has also emphasised illness
denial as a major cause of nonadherence to medication (17; 27). This is not currently
addressed in the Illness Perceptions Questionnaire. The second was the belief that it is
necessary to take treatment to avoid being hospitalised. This is a belief that is quite
specific to medications prescribed for mental disorder. Adams and Scott (28) also
reported that concerns about hospitalisation were associated with adherence to
medication. This is not currently addressed in the Beliefs about Medicines
Questionnaire.
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Once the Illness Perceptions Questionnaire and the Beliefs about Medicines
Questionnaire have been adapted to include items reflecting these additional
perceptions, two limitations of this qualitative research could be addressed through
conducting a questionnaire-based study. First, the current qualitative study involves only
a small sample and the results are therefore not generalisable. A quantitative study
would include a larger, more representative sample. This would make it possible to
compare the beliefs and adherence of different clinical and demographic groups. For
example, one might expect differences in beliefs and adherence between those with
bipolar I and bipolar II disorder, or between those with and without comorbid substance
use and anxiety disorders.
Second, although the current study identified beliefs that appeared to be associated with
nonadherence, it is not possible to quantify the relationship between the beliefs and
adherence using this design. A questionnaire-based study would enable us to see how
common different types of perceptions are amongst people with bipolar disorder and will
allow the statistical exploration of the ability of patients’ perceptions to explain
nonadherence to medication.
In conclusion, further research is now justified using a larger sample to quantify the role
of illness and treatment perceptions in adherence to medication in bipolar disorder. This
study, however, provides preliminary evidence for the importance of eliciting and
addressing patients’ perceptions of bipolar disorder and its treatment to facilitate
adherence to medication and optimum management of bipolar disorder.
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Table 1: Prescribed medication in the sample
Medication Number of participants prescribed
medication
Lithium 6
Valproate 8
Lamotrigine 2
Quetiapine 3
Olanzapine 2
Amisulpride 1
Haliperodol 2
Stelazine 1
Flupenthixol 1
SSRI antidepressants 3
Tricyclic antidepressants 1
Mirtazapine 1
Nitrazepam 3
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